| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 187.168 | 187.994 | 197.987 | 210.859 | 237.763 | 298.439 | 307.305 | 354.787 | 427.708 | 467.911 |
| Total Income - EUR | 187.172 | 187.997 | 197.990 | 211.928 | 244.039 | 303.458 | 307.312 | 354.797 | 427.716 | 467.937 |
| Total Expenses - EUR | 174.790 | 176.810 | 189.305 | 198.581 | 228.248 | 275.259 | 287.288 | 339.666 | 389.801 | 448.102 |
| Gross Profit/Loss - EUR | 12.382 | 11.187 | 8.686 | 13.347 | 15.791 | 28.199 | 20.024 | 15.131 | 37.915 | 19.836 |
| Net Profit/Loss - EUR | 10.077 | 9.161 | 6.602 | 11.208 | 13.370 | 25.562 | 17.911 | 12.217 | 34.471 | 5.915 |
| Employees | 1 | 1 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Coral-Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.958 | 16.325 | 11.426 | 8.251 | 6.992 | 21.277 | 19.570 | 22.740 | 18.725 | 12.648 |
| Current Assets | 90.595 | 70.661 | 79.039 | 86.492 | 101.890 | 120.819 | 155.151 | 140.799 | 152.998 | 169.882 |
| Inventories | 37.564 | 37.844 | 40.475 | 36.975 | 39.196 | 45.607 | 44.313 | 66.882 | 68.458 | 65.032 |
| Receivables | 23.739 | 14.657 | 33.968 | 44.306 | 41.661 | 54.517 | 60.355 | 73.353 | 76.370 | 80.772 |
| Cash | 29.292 | 18.160 | 4.596 | 5.212 | 21.032 | 20.695 | 50.483 | 564 | 8.170 | 24.079 |
| Shareholders Funds | 52.501 | 27.724 | 25.101 | 31.550 | 39.673 | 60.033 | 71.296 | 43.178 | 54.270 | 15.654 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 60.052 | 59.262 | 65.364 | 63.193 | 69.208 | 82.063 | 103.425 | 120.361 | 117.453 | 166.876 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Coral-Pharm Srl